BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 27122022)

  • 21. Unapproved Pharmaceutical Ingredients Included in Dietary Supplements Associated With US Food and Drug Administration Warnings.
    Tucker J; Fischer T; Upjohn L; Mazzera D; Kumar M
    JAMA Netw Open; 2018 Oct; 1(6):e183337. PubMed ID: 30646238
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dietary supplements: What's in a name? What's in the bottle?
    Marcus DM
    Drug Test Anal; 2016; 8(3-4):410-2. PubMed ID: 27072845
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nutraceuticals and botanicals: overview and perspectives.
    Nicoletti M
    Int J Food Sci Nutr; 2012 Mar; 63 Suppl 1():2-6. PubMed ID: 22360273
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FDA's review of scientific evidence for health claims.
    Schneeman B
    J Nutr; 2007 Feb; 137(2):493-4. PubMed ID: 17237334
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nutraceuticals: opening the debate for a regulatory framework.
    Santini A; Cammarata SM; Capone G; Ianaro A; Tenore GC; Pani L; Novellino E
    Br J Clin Pharmacol; 2018 Apr; 84(4):659-672. PubMed ID: 29433155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Twenty Years of the Dietary Supplement Health and Education Act--How Should Dietary Supplements Be Regulated?
    Wallace TC
    J Nutr; 2015 Aug; 145(8):1683-6. PubMed ID: 26063064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Dietary Supplement and Health Education Act and supplements: dietary and nutritional supplements need no more regulations.
    Wollschlaeger B
    Int J Toxicol; 2003; 22(5):387-90. PubMed ID: 14555412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regulatory aspects of diets, supplements, and nutraceuticals.
    Dzanis DA
    Clin Tech Small Anim Pract; 1998 Nov; 13(4):193-6. PubMed ID: 9842110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Why consumers need more protection against claims for dietary supplements and herbs.
    Barrett S
    Int J Toxicol; 2003; 22(5):391-2. PubMed ID: 14555413
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health-benefit claims for probiotic products.
    Heimbach JT
    Clin Infect Dis; 2008 Feb; 46 Suppl 2():S122-4; discussion S144-51. PubMed ID: 18181716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Criteria for substantiating claims.
    Aggett PJ
    Novartis Found Symp; 2007; 282():46-53; discussion 53-8, 212-8. PubMed ID: 17913223
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FDA regulation of dietary supplements and requirements regarding adverse event reporting.
    Frankos VH; Street DA; O'Neill RK
    Clin Pharmacol Ther; 2010 Feb; 87(2):239-44. PubMed ID: 20032973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety.
    Coppens P; da Silva MF; Pettman S
    Toxicology; 2006 Apr; 221(1):59-74. PubMed ID: 16469424
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences between dietary supplement and prescription drug omega-3 fatty acid formulations: a legislative and regulatory perspective.
    Collins N; Tighe AP; Brunton SA; Kris-Etherton PM
    J Am Coll Nutr; 2008 Dec; 27(6):659-66. PubMed ID: 19155425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional foods: the Food and Drug Administration perspective.
    Ross S
    Am J Clin Nutr; 2000 Jun; 71(6 Suppl):1735S-8S; discussion 1739S-42S. PubMed ID: 10837331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. What makes consumers think dietary supplements are safe and effective? The role of disclaimers and FDA approval.
    Dodge T; Kaufman A
    Health Psychol; 2007 Jul; 26(4):513-7. PubMed ID: 17605572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Maintaining a level playing field: the need for a uniform standard to evaluate health claims for foods and dietary supplements.
    Pappas CD
    Food Drug Law J; 2002; 57(1):25-41. PubMed ID: 12118479
    [No Abstract]   [Full Text] [Related]  

  • 38. The impact of cGMP compliance on consumer confidence in dietary supplement products.
    Crowley R; FitzGerald LH
    Toxicology; 2006 Apr; 221(1):9-16. PubMed ID: 16469425
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Scientific substantiation of claims in the USA: focus on functional foods.
    Lupton JR
    Eur J Nutr; 2009 Dec; 48 Suppl 1():S27-31. PubMed ID: 19937443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of botanicals in food supplements. Regulatory scope, scientific risk assessment and claim substantiation. 2005.
    Coppens P; Delmulle L; Gulati O; Richardson D; Ruthsatz M; Sievers H; Sidani S;
    Ann Nutr Metab; 2006; 50(6):538-54. PubMed ID: 17191027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.